BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 26671408)

  • 1. Determinants and Prognostic Significance of Hematoma Sedimentation Levels in Acute Intracerebral Hemorrhage.
    Sato S; Delcourt C; Zhang S; Arima H; Heeley E; Zheng D; Al-Shahi Salman R; Stapf C; Tzourio C; Robinson T; Lindley RI; Chalmers J; Anderson CS;
    Cerebrovasc Dis; 2016; 41(1-2):80-6. PubMed ID: 26671408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Practice Patterns for Neurosurgical Utilization and Outcome in Acute Intracerebral Hemorrhage: Intensive Blood Pressure Reduction in Acute Cerebral Hemorrhage Trials 1 and 2 Studies.
    Guo R; Blacker DJ; Wang X; Arima H; Lavados PM; Lindley RI; Chalmers J; Anderson CS; Robinson T;
    Neurosurgery; 2017 Dec; 81(6):980-985. PubMed ID: 28605557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of perihematomal edema in acute intracerebral hemorrhage: pooled analysis from the intensive blood pressure reduction in acute cerebral hemorrhage trial studies.
    Yang J; Arima H; Wu G; Heeley E; Delcourt C; Zhou J; Chen G; Wang X; Zhang S; Yu S; Chalmers J; Anderson CS;
    Stroke; 2015 Apr; 46(4):1009-13. PubMed ID: 25712944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. White blood cell count and clinical outcomes after intracerebral hemorrhage: The INTERACT2 trial.
    Yu S; Arima H; Heeley E; Delcourt C; Krause M; Peng B; Yang J; Wu G; Chen X; Chalmers J; Anderson CS;
    J Neurol Sci; 2016 Feb; 361():112-6. PubMed ID: 26810526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intensive Care Unit Admission for Patients in the INTERACT2 ICH Blood Pressure Treatment Trial: Characteristics, Predictors, and Outcomes.
    Wartenberg KE; Wang X; Muñoz-Venturelli P; Rabinstein AA; Lavados PM; Anderson CS; Robinson T;
    Neurocrit Care; 2017 Jun; 26(3):371-378. PubMed ID: 28000127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebral Microbleeds and the Effect of Intensive Blood Pressure Reduction on Hematoma Expansion and Functional Outcomes: A Secondary Analysis of the ATACH-2 Randomized Clinical Trial.
    Shoamanesh A; Morotti A; Romero JM; Oliveira-Filho J; Schlunk F; Jessel MJ; Ayres AM; Vashkevich A; Schwab K; Afzal MR; Cassarly C; Martin RH; Qureshi AI; Greenberg SM; Rosand J; Goldstein JN;
    JAMA Neurol; 2018 Jul; 75(7):850-859. PubMed ID: 29710119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. White Matter Hyperintensities and Blood Pressure Lowering in Acute Intracerebral Hemorrhage: A Secondary Analysis of the ATACH-2 Trial.
    Morotti A; Shoamanesh A; Oliveira-Filho J; Schlunk F; Romero JM; Jessel M; Ayres A; Vashkevich A; Schwab K; Cassarly C; Martin RH; Greenberg SM; Qureshi AI; Rosand J; Goldstein JN;
    Neurocrit Care; 2020 Feb; 32(1):180-186. PubMed ID: 31218636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Candesartan in the Acute Phase of Intracerebral Hemorrhage.
    Jusufovic M; Berge TE; Guo R; You S; Delcourt C; Anderson C; Bath PM; Karlson BW; Berge E; Sandset EC;
    J Stroke Cerebrovasc Dis; 2019 Aug; 28(8):2262-2267. PubMed ID: 31178359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hematoma growth and outcomes in intracerebral hemorrhage: the INTERACT1 study.
    Delcourt C; Huang Y; Arima H; Chalmers J; Davis SM; Heeley EL; Wang J; Parsons MW; Liu G; Anderson CS;
    Neurology; 2012 Jul; 79(4):314-9. PubMed ID: 22744655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of Hematoma Shape and Density in Intracerebral Hemorrhage: The Intensive Blood Pressure Reduction in Acute Intracerebral Hemorrhage Trial Study.
    Delcourt C; Zhang S; Arima H; Sato S; Al-Shahi Salman R; Wang X; Davies L; Stapf C; Robinson T; Lavados PM; Chalmers J; Heeley E; Liu M; Lindley RI; Anderson CS;
    Stroke; 2016 May; 47(5):1227-32. PubMed ID: 27073236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of early pyrexia in acute intracerebral haemorrhage: The INTERACT2 study.
    Malavera A; You S; Zheng D; Delcourt C; Anderson CS;
    J Neurol Sci; 2021 Apr; 423():117364. PubMed ID: 33647734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of the high admission blood pressure in mild-to-moderate acute intracerebral hemorrhage.
    Wang X; Sandset EC; Moullaali TJ; Chen G; Song L; Carcel C; Delcourt C; Woodward M; Robinson T; Chalmers J; Arima H; Anderson CS;
    J Hypertens; 2019 Jul; 37(7):1463-1466. PubMed ID: 31085948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early Deterioration, Hematoma Expansion, and Outcomes in Deep Versus Lobar Intracerebral Hemorrhage: The FAST Trial.
    Kuohn LR; Witsch J; Steiner T; Sheth KN; Kamel H; Navi BB; Merkler AE; Murthy SB; Mayer SA
    Stroke; 2022 Aug; 53(8):2441-2448. PubMed ID: 35360929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood pressure reduction and noncontrast CT markers of intracerebral hemorrhage expansion.
    Morotti A; Boulouis G; Romero JM; Brouwers HB; Jessel MJ; Vashkevich A; Schwab K; Afzal MR; Cassarly C; Greenberg SM; Martin RH; Qureshi AI; Rosand J; Goldstein JN;
    Neurology; 2017 Aug; 89(6):548-554. PubMed ID: 28701501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensive Blood Pressure Lowering in Patients with Moderate to Severe Grade Acute Cerebral Hemorrhage: Post Hoc Analysis of Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH)-2 Trial.
    Qureshi AI; Foster LD; Lobanova I; Huang W; Suarez JI
    Cerebrovasc Dis; 2020; 49(3):244-252. PubMed ID: 32585668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The speed of ultraearly hematoma growth in acute intracerebral hemorrhage.
    Sato S; Arima H; Hirakawa Y; Heeley E; Delcourt C; Beer R; Li Y; Zhang J; Jüettler E; Wang J; Lavados PM; Robinson T; Lindley RI; Chalmers J; Anderson CS;
    Neurology; 2014 Dec; 83(24):2232-8. PubMed ID: 25378675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early Achievement of Blood Pressure Lowering and Hematoma Growth in Acute Intracerebral Hemorrhage: Stroke Acute Management with Urgent Risk-Factor Assessment and Improvement-Intracerebral Hemorrhage Study.
    Yamaguchi Y; Koga M; Sato S; Yamagami H; Todo K; Okuda S; Okada Y; Kimura K; Shiokawa Y; Kamiyama K; Itabashi R; Hasegawa Y; Kario K; Fujita K; Kumamoto M; Kamimura T; Ando D; Ide T; Yoshimoto T; Shiozawa M; Matsubara S; Yoshimura S; Nagatsuka K; Toyoda K;
    Cerebrovasc Dis; 2018; 46(3-4):118-124. PubMed ID: 30199854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late Neurological Deterioration after Acute Intracerebral Hemorrhage: A post hoc Analysis of the ATACH-2 Trial.
    Okazaki S; Yamamoto H; Foster LD; Fukuda-Doi M; Koga M; Ihara M; Toyoda K; Palesch YY; Qureshi AI
    Cerebrovasc Dis; 2020; 49(1):26-31. PubMed ID: 32045911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood pressure management in acute intracerebral hemorrhage: relationship between elevated blood pressure and hematoma enlargement.
    Ohwaki K; Yano E; Nagashima H; Hirata M; Nakagomi T; Tamura A
    Stroke; 2004 Jun; 35(6):1364-7. PubMed ID: 15118169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of delayed intraventricular haemorrhage in the INTERACT studies.
    Moullaali TJ; Sato S; Wang X; Rabinstein AA; Arima H; Carcel C; Chen G; Robinson T; Heeley E; Chan E; Delcourt C; Stapf C; Cordonnier C; Lindley RI; Chalmers J; Anderson CS;
    J Neurol Neurosurg Psychiatry; 2017 Jan; 88(1):19-24. PubMed ID: 26746184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.